SHARE THIS VIDEO —
New drugs revolutionizing weight-loss and health care
The FDA has approved Zepbound, the latest in a growing number of drugs that are revolutionizing weight loss as America faces an epidemic of obesity. Will insurance companies begin to cover the cost and are doctors sure they are safe? NBC’s Liz Kreutz reports in this week’s Sunday Focus. **CORRECTION: An earlier version of this story incorrectly stated that Eli Lilly’s Mounjaro has only been approved for people with pre-diabetes. It has now been updated to reflect that Mounjaro has been approved for people with pre-diabetes and Type 2 diabetes.**